Report Detail
Global (United States, European Union and China) Celiac Drugs Market Research Report 2019-2025
- RnM3691334 |
- 23 August, 2019 |
- Global |
- 121 Pages |
- QYResearch |
- Pharma & Healthcare
Celiac disease, also known as celiac sprue or gluten-sensitive enteropathy, is a genetic autoimmune disorder caused due to the body’s inability to process gluten that causes damage to the small intestine. Gluten, a protein found in wheat, barley, and rye, can damage the lining of the small intestine which makes it difficult for the body to absorb nutrients such as iron, fat, calcium, and folate. The immune system mistakes substances inside gluten to be a threat to the body and attacks them, in turn, causing damage to the bowel surface and hampering the body’s ability to absorb nutrition. Digestion problems, dermatitis herpetiformis, abdominal pain, weight loss, musculoskeletal problems, aphthous ulcers, iron deficiency, stunted growth, tingling sensation in the leg, and missed menstrual cycles are some of the symptoms of celiac disease. The disease can lead to various complications and health problems such as miscarriage or infertility, intestinal cancer, osteoporosis, seizures, gall bladder malfunction, neurological manifestation of the disease, stunted growth in children, and birth defects. Celiac disease can also lead to various autoimmune diseases such as lupus, thyroid disease, Sjögren's syndrome, type 1 diabetes, and rheumatoid arthritis. It is difficult to diagnose celiac disease in the initial stages as its symptoms are similar to those of other diseases. Various sensitive and selective blood tests such as anti-tissue transglutaminase antibodies with or without IgA level and IgA anti-endomysial antibodies are used to screen the disease.
North America dominates the global market for celiac drugs due to rising incidence of celiac disease and lack of treatment options in the region. Asia is expected to show high growth rates in the next five years in global celiac drugs market, with China and India being the fastest growing markets in the Asia-Pacific region. The key driving forces for the celiac drugs market in developing countries are the large pool of patients, increasing awareness about the disease, and rising government funding in the region.
In 2019, the market size of Celiac Drugs is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Celiac Drugs.
This report studies the global market size of Celiac Drugs, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Celiac Drugs sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
ADMA Biologics
Amgen
Anthera Pharmaceuticals
Bayer
Biogen
BioLineRx
Biotest
Bristol-Myers Squibb
Celgene
Celimmune
F Hoffmann-La Roche
ImmunogenX
Immunomedics
ImmusanT
Innovate Biopharmaceuticals
Johnson & Johnson
Kedrion Biopharma
LFB Group
Merck
Novartis
Market Segment by Product Type
First Line Of Treatment
Second Line Of Treatment
Market Segment by Application
Men
Women
Children
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Celiac Drugs status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Celiac Drugs manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Celiac Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Celiac Drugs Market Size Growth Rate by Type (2019-2025)
- 1.3.2 First Line Of Treatment
- 1.3.3 Second Line Of Treatment
- 1.4 Market Segment by Application
- 1.4.1 Global Celiac Drugs Market Share by Application (2019-2025)
- 1.4.2 Men
- 1.4.3 Women
- 1.4.4 Children
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Celiac Drugs Market Size
- 2.1.1 Global Celiac Drugs Revenue 2014-2025
- 2.1.2 Global Celiac Drugs Sales 2014-2025
- 2.2 Celiac Drugs Growth Rate by Regions
- 2.2.1 Global Celiac Drugs Sales by Regions 2014-2019
- 2.2.2 Global Celiac Drugs Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Celiac Drugs Sales by Manufacturers
- 3.1.1 Celiac Drugs Sales by Manufacturers 2014-2019
- 3.1.2 Celiac Drugs Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Celiac Drugs Revenue by Manufacturers (2014-2019)
- 3.2.2 Celiac Drugs Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Celiac Drugs Market Concentration Ratio (CR5 and HHI)
- 3.3 Celiac Drugs Price by Manufacturers
- 3.4 Key Manufacturers Celiac Drugs Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Celiac Drugs Market
- 3.6 Key Manufacturers Celiac Drugs Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 First Line Of Treatment Sales and Revenue (2014-2019)
- 4.1.2 Second Line Of Treatment Sales and Revenue (2014-2019)
- 4.2 Global Celiac Drugs Sales Market Share by Type
- 4.3 Global Celiac Drugs Revenue Market Share by Type
- 4.4 Celiac Drugs Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Celiac Drugs Sales by Application
6 United States
- 6.1 United States Celiac Drugs Breakdown Data by Company
- 6.2 United States Celiac Drugs Breakdown Data by Type
- 6.3 United States Celiac Drugs Breakdown Data by Application
7 European Union
- 7.1 European Union Celiac Drugs Breakdown Data by Company
- 7.2 European Union Celiac Drugs Breakdown Data by Type
- 7.3 European Union Celiac Drugs Breakdown Data by Application
8 China
- 8.1 China Celiac Drugs Breakdown Data by Company
- 8.2 China Celiac Drugs Breakdown Data by Type
- 8.3 China Celiac Drugs Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Celiac Drugs Breakdown Data by Company
- 9.2 Rest of World Celiac Drugs Breakdown Data by Type
- 9.3 Rest of World Celiac Drugs Breakdown Data by Application
- 9.4 Rest of World Celiac Drugs Breakdown Data by Countries
- 9.4.1 Rest of World Celiac Drugs Sales by Countries
- 9.4.2 Rest of World Celiac Drugs Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 ADMA Biologics
- 10.1.1 ADMA Biologics Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Celiac Drugs
- 10.1.4 Celiac Drugs Product Introduction
- 10.1.5 ADMA Biologics Recent Development
- 10.2 Amgen
- 10.2.1 Amgen Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Celiac Drugs
- 10.2.4 Celiac Drugs Product Introduction
- 10.2.5 Amgen Recent Development
- 10.3 Anthera Pharmaceuticals
- 10.3.1 Anthera Pharmaceuticals Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Celiac Drugs
- 10.3.4 Celiac Drugs Product Introduction
- 10.3.5 Anthera Pharmaceuticals Recent Development
- 10.4 Bayer
- 10.4.1 Bayer Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Celiac Drugs
- 10.4.4 Celiac Drugs Product Introduction
- 10.4.5 Bayer Recent Development
- 10.5 Biogen
- 10.5.1 Biogen Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Celiac Drugs
- 10.5.4 Celiac Drugs Product Introduction
- 10.5.5 Biogen Recent Development
- 10.6 BioLineRx
- 10.6.1 BioLineRx Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Celiac Drugs
- 10.6.4 Celiac Drugs Product Introduction
- 10.6.5 BioLineRx Recent Development
- 10.7 Biotest
- 10.7.1 Biotest Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Celiac Drugs
- 10.7.4 Celiac Drugs Product Introduction
- 10.7.5 Biotest Recent Development
- 10.8 Bristol-Myers Squibb
- 10.8.1 Bristol-Myers Squibb Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Celiac Drugs
- 10.8.4 Celiac Drugs Product Introduction
- 10.8.5 Bristol-Myers Squibb Recent Development
- 10.9 Celgene
- 10.9.1 Celgene Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Celiac Drugs
- 10.9.4 Celiac Drugs Product Introduction
- 10.9.5 Celgene Recent Development
- 10.10 Celimmune
- 10.10.1 Celimmune Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of Celiac Drugs
- 10.10.4 Celiac Drugs Product Introduction
- 10.10.5 Celimmune Recent Development
- 10.11 F Hoffmann-La Roche
- 10.12 ImmunogenX
- 10.13 Immunomedics
- 10.14 ImmusanT
- 10.15 Innovate Biopharmaceuticals
- 10.16 Johnson & Johnson
- 10.17 Kedrion Biopharma
- 10.18 LFB Group
- 10.19 Merck
- 10.20 Novartis
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Celiac Drugs Sales Channels
- 11.2.2 Celiac Drugs Distributors
- 11.3 Celiac Drugs Customers
12 Market Forecast
- 12.1 Global Celiac Drugs Sales and Revenue Forecast 2019-2025
- 12.2 Global Celiac Drugs Sales Forecast by Type
- 12.3 Global Celiac Drugs Sales Forecast by Application
- 12.4 Celiac Drugs Forecast by Regions
- 12.4.1 Global Celiac Drugs Sales Forecast by Regions 2019-2025
- 12.4.2 Global Celiac Drugs Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Celiac Drugs. Industry analysis & Market Report on Celiac Drugs is a syndicated market report, published as Global (United States, European Union and China) Celiac Drugs Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Celiac Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
